atezolizumab,cobimetinib,talazoparib,abemaciclib,pembrolizumab,regorafenib,sunitinib,temsirolimus,palbociclib,ipilimumab,larotrectinib,vemurafenib,olaparib,futibatinib,crizotinib,nivolumab,trastuzumab,entrectinib,tucatinib,pertuzumab
seagen,merck,eli lilly,bayer,bms,roche,astrazeneca,pfizer,otsuka
['tapur', 'crizotinib']
#cedarssinaicancer at #aacr23. dr. inderjit mehmi &amp; dr. kristopher wentzel are co-authors on #crizotinib in patients with solid #tumors with met amplification or mutation: results from the targeted agent and profiling utilization registry (tapur) study 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.